Watson P, DeVaux C, Freeman K
Sci Rep. 2025; 15(1):8716.
PMID: 40082458
PMC: 11906763.
DOI: 10.1038/s41598-025-91688-4.
Hua Z, Gong B, Li Z
Mol Neurobiol. 2025; .
PMID: 39979690
DOI: 10.1007/s12035-025-04759-y.
Cheng J, Sun M, Dong X, Yang Y, Qin X, Zhou X
BMC Cancer. 2025; 25(1):161.
PMID: 39875895
PMC: 11773968.
DOI: 10.1186/s12885-025-13560-y.
Cheng J, Dong X, Yang Y, Qin X, Zhou X, Zhang D
Transl Pediatr. 2025; 13(12):2164-2182.
PMID: 39822999
PMC: 11732634.
DOI: 10.21037/tp-24-323.
Cardus D, Smith M, Vernaza A, Smith J, Del Buono B, Parajuli A
Genes (Basel). 2024; 15(10).
PMID: 39457392
PMC: 11507652.
DOI: 10.3390/genes15101268.
Research status and development trends of omics in neuroblastoma a bibliometric and visualization analysis.
Han M, Niu H, Duan F, Wang Z, Zhang Z, Ren H
Front Oncol. 2024; 14:1383805.
PMID: 39450262
PMC: 11499224.
DOI: 10.3389/fonc.2024.1383805.
Exercise and tumor proteome: insights from a neuroblastoma model.
Plaza-Florido A, Galvez B, Lopez J, Santos-Lozano A, Zazo S, Rincon-Castanedo C
Physiol Genomics. 2024; 56(12):833-844.
PMID: 39311839
PMC: 11573273.
DOI: 10.1152/physiolgenomics.00064.2024.
Expansion of a neural crest gene signature following ectopic MYCN expression in sympathoadrenal lineage cells in vivo.
Ibarra-Garcia-Padilla R, Nambiar A, Hamre T, Singleton E, Uribe R
PLoS One. 2024; 19(9):e0310727.
PMID: 39292691
PMC: 11410271.
DOI: 10.1371/journal.pone.0310727.
Insight into the Role of the miR-584 Family in Human Cancers.
Braile M, Luciano N, Carlomagno D, Salvatore G, Orlandella F
Int J Mol Sci. 2024; 25(13).
PMID: 39000555
PMC: 11242779.
DOI: 10.3390/ijms25137448.
Integrated re-analysis of transcriptomic and proteomic datasets reveals potential mechanisms for Zika viral-based oncolytic therapy in neuroblastoma.
Sherwood M, Zhou Y, Sui Y, Wang Y, Skipp P, Kaid C
F1000Res. 2024; 12:719.
PMID: 38903860
PMC: 11187533.
DOI: 10.12688/f1000research.132627.3.
An integrated single-cell RNA-seq map of human neuroblastoma tumors and preclinical models uncovers divergent mesenchymal-like gene expression programs.
Chapple R, Liu X, Natarajan S, Alexander M, Kim Y, Patel A
Genome Biol. 2024; 25(1):161.
PMID: 38898465
PMC: 11186099.
DOI: 10.1186/s13059-024-03309-4.
SAP30, an oncogenic driver of progression, poor survival, and drug resistance in neuroblastoma.
Prathipati P, Pathania A, Chaturvedi N, Gupta S, Byrareddy S, Coulter D
Mol Ther Nucleic Acids. 2024; 35(2):101543.
PMID: 38817681
PMC: 11137595.
DOI: 10.1016/j.omtn.2022.03.014.
Nuclear factor-κB activation by transforming growth factor-β1 drives tumour microenvironment-mediated drug resistance in neuroblastoma.
Louault K, Blavier L, Lee M, Kennedy R, Fernandez G, Pawel B
Br J Cancer. 2024; 131(1):90-100.
PMID: 38806726
PMC: 11231159.
DOI: 10.1038/s41416-024-02686-8.
The Neuroblastoma Microenvironment, Heterogeneity and Immunotherapeutic Approaches.
Polychronopoulos P, Bedoya-Reina O, Johnsen J
Cancers (Basel). 2024; 16(10).
PMID: 38791942
PMC: 11119056.
DOI: 10.3390/cancers16101863.
Molecular Characterization and Inhibition of a Novel Stress-Induced Mitochondrial Protecting Role for Misfolded TrkAIII in Human SH-SY5Y Neuroblastoma Cells.
Cappabianca L, Ruggieri M, Sebastiano M, Sbaffone M, Martelli I, Ruggeri P
Int J Mol Sci. 2024; 25(10).
PMID: 38791513
PMC: 11122047.
DOI: 10.3390/ijms25105475.
A multi-omics approach for biomarker discovery in neuroblastoma: a network-based framework.
Hussein R, Abou-Shanab A, Badr E
NPJ Syst Biol Appl. 2024; 10(1):52.
PMID: 38760476
PMC: 11101461.
DOI: 10.1038/s41540-024-00371-3.
Extracellular Vesicles for Childhood Cancer Liquid Biopsy.
Singhto N, Pongphitcha P, Jinawath N, Hongeng S, Chutipongtanate S
Cancers (Basel). 2024; 16(9).
PMID: 38730633
PMC: 11083250.
DOI: 10.3390/cancers16091681.
Unsaturated Fatty Acid Synthesis Is Associated with Worse Survival and Is Differentially Regulated by and Tumor Suppressor microRNAs in Neuroblastoma.
Sheeter D, Garza S, Park H, Benhamou L, Badi N, Espinosa E
Cancers (Basel). 2024; 16(8).
PMID: 38672672
PMC: 11048984.
DOI: 10.3390/cancers16081590.
Nuclear miRNAs as transcriptional regulators in processes related to various cancers (Review).
Wang Z, Zhang Y, Li K
Int J Oncol. 2024; 64(5).
PMID: 38606502
PMC: 11015916.
DOI: 10.3892/ijo.2024.5644.
Pediatric Solid Cancers: Dissecting the Tumor Microenvironment to Improve the Results of Clinical Immunotherapy.
Belgiovine C, Mebelli K, Raffaele A, De Cicco M, Rotella J, Pedrazzoli P
Int J Mol Sci. 2024; 25(6).
PMID: 38542199
PMC: 10970338.
DOI: 10.3390/ijms25063225.